Crizotinib price after reimbursement

Crizotinib is a targeted agent indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors test positive for anaplastic lymphoma kinase (ALK) or ROS1 in an FDA-approved test. As well as for the treatment of pediatric patients and young patients aged 1 and above with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL) and ALK positive. and the treatment of adult and pediatric patients aged 1 year and older with ALK-positive unresectable, recurrent or refractory inflammatory myofibroblastic tumor (IMT).

Crizotinib is a first-generation targeted drug that was launched in China in2013. What is the price of crizotinib after reimbursement? Different provinces have different patient reimbursement ratio policies, so the reimbursement of drugs will vary. Generally, crizotinib is reimbursed for more than 5,000 per box. If patients are under great financial pressure, they can also use overseas generic drugs, which are more cost-effective. Different versions have different prices, but compared with domestically imported drugs, the prices are still more favorable. The retail price of the second pharmaceutical manufacturer in Laos is about 2600yuan, and the retail price of the second pharmaceutical manufacturer in Laos and ASEAN is 200mg60capsules pan>5100yuan, 250mg60 tablets5800yuan. The price of 250 mg 60 tablets of Laos Element Pharmaceuticals is around 2,600 yuan, the retail price of Beacon Pharmaceuticals in Bangladesh is around 3,900 yuan, and the retail price of Yaopin International in Bangladesh is around 2,700 yuan. Patients can choose the version according to their financial situation. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.

xa0

xa0

xa0

xa0

xa0